Literature DB >> 10720275

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

A J Rothdach1, C Trenkwalder, J Haberstock, U Keil, K Berger.   

Abstract

OBJECTIVE: To evaluate prevalence, sociodemographic characteristics, and risk factors of restless legs syndrome (RLS) in a population-based survey of the elderly, using standard diagnostic criteria.
BACKGROUND: Population-based studies of RLS are rare and have not yet used standard definition criteria.
METHODS: The Memory and Morbidity in Augsburg Elderly (MEMO) Study is a follow-up project of the World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) Survey-Augsburg, Germany, 1989-1990, evaluating neurologic diseases and their risk factors in a German population 65 to 83 years of age. Two RLS-trained physicians assessed the prevalence of RLS based on the four minimal standard criteria (International Restless Legs Syndrome Study Group, 1995) using standardized questions in face-to-face interviews. They also obtained information on medical history, medications, depression (Center of Epidemiologic Studies Depression Scale), and quality of life (Short Form 36) and performed a standardized neurologic examination for each participant.
RESULTS: The study population included 369 participants (173 women and 196 men). The overall prevalence of RLS was 9.8% (n = 36) and higher in women (13.9% versus 6.1%; p = 0.02). In women, the prevalence did not change with age, whereas men showed a nonsignificant inverse trend with increasing age. RLS-positive individuals took more benzodiazepines and estrogen compared with non-RLS cases, but the differences were not statistically significant. Participants with RLS had higher incidence of depression (p = 0.012) and lower self-reported mental health scores (p = 0.029) than did non-RLS cases.
CONCLUSIONS: RLS is a frequent syndrome in the elderly with considerable impact on self-perceived mental health, affecting women about twice as often as men.

Entities:  

Mesh:

Year:  2000        PMID: 10720275     DOI: 10.1212/wnl.54.5.1064

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  121 in total

Review 1.  Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Authors:  Svenja Happe; Claudia Trenkwalder
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

3.  Restless legs syndrome: what have we learned from prevalence studies and how will incidence studies further clinical knowledge?

Authors:  Daniel L Picchietti; Matthew A Picchietti
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

Review 4.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

5.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

Review 6.  Management of restless legs syndrome in patients on dialysis.

Authors:  Miklos Z Molnar; Marta Novak; Istvan Mucsi
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 7.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

8.  Elevated estradiol plasma levels in women with restless legs during pregnancy.

Authors:  Andrea Dzaja; Renate Wehrle; Marike Lancel; Thomas Pollmächer
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

9.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

10.  Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p.

Authors:  Shenghan Chen; William G Ondo; Shaoqi Rao; Lin Li; Qiuyun Chen; Qing Wang
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.